Anika Therapeutics Inc.
ANIK | NASDAQ
$20.79
+$0.09 (+0.43%)
Sep 22, 2026, 1:48 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -12.64 | -4.30 | -4.02 | -29.02 | 123.55 | -26.78 |
PEG Ratio | 0.16 | 0.13 | -0.01 | 0.06 | -1.05 | 0.14 |
PS Ratio | 1.22 | 2.02 | 2.75 | 3.79 | 3.49 | 4.93 |
PB Ratio | 0.96 | 1.57 | 1.56 | 1.51 | 1.80 | 2.36 |
P/FCF Ratio | 31.59 | -103.95 | -46.03 | -140.07 | 158.57 | 56.28 |
P/OCF Ratio | 12.32 | 44.85 | -185.74 | 97.76 | 61.45 | 49.27 |
OCF/S Ratio | 9.92 | 4.51 | -1.48 | 3.87 | 5.68 | 10.01 |
Debt / Equity Ratio | 0.18 | 0.17 | 0.13 | 0.11 | 0.07 | 0.08 |
Quick Ratio | 3.86 | 3.85 | 4.47 | 4.65 | 4.45 | 3.56 |
Current Ratio | 4.72 | 4.88 | 5.26 | 6.07 | 5.66 | 4.81 |
Asset Turnover | 0.59 | 0.59 | 0.45 | 0.33 | 0.43 | 0.36 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -35.40 |
Return on Equity | -7.58% | -36.62% | -38.95% | -5.20% | 1.44% | -8.80% |
Return on Assets | -5.72% | -27.81% | -30.55% | -4.26% | 1.19% | -6.56% |
Return on Invested Capital | -6.48% | -2.81% | -0.38% | 0.58% | 0.82% | -7.18% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 56.56% | 63.38% | 68.33% | 64.33% | 56.12% | 52.91% |
Net Profit Margin | -9.64% | -47.02% | -68.44% | -13.05% | 2.80% | -18.38% |
Pretax Profit Margin | -8.25% | -2.31% | 2.61% | 3.80% | 1.64% | -21.94% |
Operating Profit Margin | -9.80% | -4.25% | 0.70% | 3.22% | 1.77% | -21.71% |
FCF Margin | 3.87% | -1.94% | -5.97% | -2.70% | 2.20% | 8.77% |
EBITDA Margin | -3.17% | 4.47% | 14.38% | 16.53% | -2.82% | -0.77% |
Add to Watchlist
Select watchlists to add or remove ANIK